Shuichiro Fujinaga

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 49

Top Topics

Systemic Lupus Erythematosus

Congenital Heart Disease

Top Venues

Pediatric nephrology (Berlin, Germany)

Clinical and experimental nephrology

Pediatrics international : official journal of the Japan Pediatric Society

International journal of urology : official journal of the Japanese Urological Association

This page only lists publications with an associated author ORCID identifier.

Publications

Shuichiro Fujinaga
Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome. Pediatric nephrology (Berlin, Germany) (2024)
Shuichiro Fujinaga
Timing and selection of steroid-sparing agents for children with early-stage steroid-sensitive nephrotic syndrome. Pediatric nephrology (Berlin, Germany) (2024)
Shuichiro Fujinaga
Timing and selection of steroid-sparing agents for children with early-stage steroid-sensitive nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 39 (8) (2024)
Shuichiro Fujinaga
Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 39 (9) (2024)
Shuichiro Fujinaga, Yoshitaka Watanabe
Significance of kidney biopsy and genetic analysis for atypical nephrotic syndrome with mild hypoalbuminemia: is the cut-off of 3.0 g/dL appropriate in the definition of hypoalbuminemia? Pediatric nephrology (Berlin, Germany) (2024)
Toshimasa Morishita, Shuichiro Fujinaga, Koji Sakuraya
Necessity of cyclosporine for minimal change disease with transient remission during initial 4-week prednisolone treatment: is it steroid-sensitive or steroid-resistant nephrotic syndrome? Pediatric nephrology (Berlin, Germany) (2024)
Shuichiro Fujinaga
Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 39 (9) (2024)
Yusuke Gonda, Shuichiro Fujinaga
Optimal course of pre-emptive rituximab administration for long-term disease remission in patients with complicated steroid-dependent nephrotic syndrome requiring immunosuppressive agents after rituximab. Clinical and experimental nephrology (2024)
Yusuke Gonda, Shuichiro Fujinaga
Optimal course of pre-emptive rituximab administration for long-term disease remission in patients with complicated steroid-dependent nephrotic syndrome requiring immunosuppressive agents after rituximab. Clinical and experimental nephrology 28 (9) (2024)
Tomohiko Nishino, Yoshitaka Watanabe, Mayu Nakagawa, Shuichiro Fujinaga
Childhood serum creatinine levels in children with Down syndrome complicated by congenital heart disease: A retrospective study. Pediatrics international : official journal of the Japan Pediatric Society 66 (1) (2024)
Hiroki Miyano, Shuichiro Fujinaga
Factors predicting persistent proteinuria in children with acute poststreptococcal glomerulonephritis: a tertiary center experience in Japan. Pediatric nephrology (Berlin, Germany) (2023)
Toshimasa Morishita, Shuichiro Fujinaga
Changes in adverse events after multiple rituximab courses in patients with complicated steroid-dependent nephrotic syndrome. Clinical and experimental nephrology (2023)
Yoichi Takemasa, Shuichiro Fujinaga, Mayu Nakagawa, Koji Sakuraya, Daishi Hirano
Adult survivors of childhood-onset steroid-dependent and steroid-resistant nephrotic syndrome treated with cyclosporine: a long-term single-center experience. Pediatric nephrology (Berlin, Germany) (2023)
Rie Ohyama, Shuichiro Fujinaga, Koji Sakuraya, Daishi Hirano, Shuichi Ito
Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study. Clinical and experimental nephrology (2023)
Shuichiro Fujinaga, Kanako Saito
Initial treatment with tonsillectomy combined with intravenous methylprednisolone pulse - another option for Japanese children with severe nephrotic IgA vasculitis with nephritis. Pediatric nephrology (Berlin, Germany) (2023)
Shuichiro Fujinaga, Koji Sakuraya
High prevalence of pathogenic variants in Japanese children with steroid-resistant nephrotic syndrome without edema detected by urine screening program. Pediatric nephrology (Berlin, Germany) (2023)
Shuichiro Fujinaga, Daiju Oba
Necessity of genetic testing on asymptomatic proteinuria before the progression of nephrotic syndrome in children with focal segmental glomerulosclerosis. Pediatric nephrology (Berlin, Germany) (2023)
Yusuke Gonda, Shuichiro Fujinaga, Hiroki Miyano
Combination treatment with vibegron and solifenacin for refractory non-monosymptomatic enuresis. Pediatrics international : official journal of the Japan Pediatric Society 65 (1) (2023)
Shuichiro Fujinaga, Koji Sakuraya
High prevalence of pathogenic variants in Japanese children with steroid-resistant nephrotic syndrome without edema detected by urine screening program. Pediatric nephrology (Berlin, Germany) (2023)
Shota Endo, Shuichiro Fujinaga, Yoichi Takemasa, Yuta Oonuki, Koji Sakuraya
Thrombotic thrombocytopenic purpura as initial presentation of systemic lupus erythematosus. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Shuichiro Fujinaga, Yuta Onuki
Efficacy of vibegron for refractory enuresis after combination therapy with desmopressin, solifenacin, and wireless alarm. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Shuichiro Fujinaga, Mayu Nakagawa
Definition of low nocturnal bladder capacity in Japanese enuretic children. Pediatrics international : official journal of the Japan Pediatric Society 63 (11) (2022)
Yoshitaka Watanabe, Shuichiro Fujinaga, Koji Sakuraya, Hirokazu Ikeda, Kandai Nozu
Clinical, pathological, and genetic characteristics of cases with asymptomatic proteinuria not manifesting nephrotic syndrome at onset: a single-center retrospective study. Clinical and experimental nephrology 26 (5) (2022)
Yuta Onuki, Shuichiro Fujinaga
Long-term prognosis of rituximab-induced hypogammaglobulinemia in children with complicated steroid-dependent nephrotic syndrome: impact of multiple rituximab courses. Pediatric nephrology (Berlin, Germany) (2022)
Shuichiro Fujinaga, Shota Endo
Anti-B cell strategy for complicated steroid-dependent nephrotic syndrome in children with antirituximab antibodies. Pediatric nephrology (Berlin, Germany) 37 (10) (2022)
Shuichiro Fujinaga, Yoichi Takemasa
Impact of methylprednisolone pulse therapy on anthropometric outcomes in children with immunoglobulin A nephropathy and Henoch-Schönlein purpura nephritis. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Tomohiko Nishino, Shota Endo, Hiroki Miyano, Chisato Umeda, Yuji Tomii, Yoshitaka Watanabe, Mayu Nakagawa, Daisuke Kakegawa, Shuichiro Fujinaga
Is the estimated glomerular filtration rate formula useful for evaluating the renal function of Down syndrome? Pediatrics international : official journal of the Japan Pediatric Society 63 (8) (2021)
Shuichiro Fujinaga, Shota Endo, Yuta Onuki
Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome. Clinical and experimental nephrology 25 (4) (2021)
Yoichi Takemasa, Shuichiro Fujinaga
Adult chronic kidney disease in childhood-onset nephrotic syndrome. Pediatrics international : official journal of the Japan Pediatric Society (2021)
Shuichiro Fujinaga, Yoshitaka Watanabe, Mayu Nakagawa
Efficacy of the novel selective β3-adrenoreceptor agonist vibegron for treatment-resistant monosymptomatic nocturnal enuresis in children. International journal of urology : official journal of the Japanese Urological Association 27 (8) (2020)
Shuichiro Fujinaga, Akira Mizutani
Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome? Clinical and experimental nephrology 24 (12) (2020)
Shuichiro Fujinaga, Chisato Umeda
Risk factor for persistent proteinuria in adulthood after clinical remission in Japanese children with immunoglobulin A nephropathy: impact of tonsillectomy combined with intravenous pulse methylprednisolone. Clinical and experimental nephrology 24 (8) (2020)
Yoshitaka Watanabe, Shuichiro Fujinaga, Amane Endo, Shota Endo, Mayu Nakagawa, Koji Sakuraya
Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology. Pediatric nephrology (Berlin, Germany) 35 (12) (2020)
Shuichiro Fujinaga, Yuji Tomii
Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome. Clinical and experimental nephrology 24 (4) (2020)
Shuichiro Fujinaga, Tomohiko Nishino, Shota Endo, Chisato Umeda, Yoshitaka Watanabe, Mayu Nakagawa
Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 35 (10) (2020)
Shuichiro Fujinaga, Tomohiko Nishino, Yasuko Urushihara
Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome. Clinical and experimental nephrology 25 (2) (2020)
Shuichiro Fujinaga, Koji Sakuraya
Inhibitory effect of steroid on absorption fever after percutaneous renal biopsy. Pediatrics international : official journal of the Japan Pediatric Society 61 (5) (2019)
Shuichiro Fujinaga, Daishi Hirano, Tomohiko Nishino, Chisato Umeda, Yoshitaka Watanabe, Mayu Nakagawa
Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine. Pediatric nephrology (Berlin, Germany) 34 (11) (2019)
Shuichiro Fujinaga, Kanako Kusaba
Impact of acute kidney injury at the onset of idiopathic nephrotic syndrome in Japanese children. Clinical and experimental nephrology 23 (9) (2019)
Shuichiro Fujinaga, Koji Sakuraya
Spontaneous femoral artery thrombosis in childhood-onset nephrotic syndrome. Pediatrics international : official journal of the Japan Pediatric Society 61 (5) (2019)
Shuichiro Fujinaga, Yusuke Gonda
Two different clinical aspects of Japanese children with asymptomatic nephrotic syndrome at onset. Clinical and experimental nephrology 23 (5) (2019)
Shuichiro Fujinaga, Yuji Tomii
Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 34 (7) (2019)
Shuichiro Fujinaga, Tomohiko Nishino
Risk factors for early B cell recovery following single-dose rituximab therapy in Japanese children with steroid-dependent nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 34 (2) (2018)
Shuichiro Fujinaga, Koji Sakuraya
Initial prednisolone dosing for the first relapse of steroid-sensitive nephrotic syndrome in Japanese children. Pediatric nephrology (Berlin, Germany) 33 (11) (2018)
Shuichiro Fujinaga, Tomohiko Nishino, Chisato Umeda, Yuji Tomii, Yoshitaka Watanabe, Koji Sakuraya
Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 34 (2) (2018)
Akira Mizutani, Shuichiro Fujinaga, Koji Sakuraya, Daishi Hirano, Toshiaki Shimizu
Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Clinical and experimental nephrology 23 (2) (2018)
Shuichiro Fujinaga, Tomohiko Nishino
Is cytokine-release syndrome the cause of rituximab treatment-related infusion reactions in children with nephrotic syndrome? Impact of anti-rituximab antibodies. Pediatric nephrology (Berlin, Germany) 33 (6) (2018)
Shuichiro Fujinaga, Koji Sakuraya
Should mycophenolate mofetil be administered prior to cyclosporine A as a steroid-sparing agent to children with steroid-dependent nephrotic syndrome? Pediatric nephrology (Berlin, Germany) 33 (12) (2018)
Shuichiro Fujinaga, Koji Sakuraya
Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodies. Pediatric nephrology (Berlin, Germany) 33 (3) (2017)